New Biotech Offering Targets $426B Rare Disease Market

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program

Vandana Singh
April 11, 2024

Thursday, Enliven Therapeutics Inc (NASDAQ:ELVN) released proof of concept data from the Phase 1 clinical trial evaluating ELVN-001 in patients with chronic myeloid leukemia (CML) who are relapsed, refractory, or intolerant to available tyrosine kinase inhibitors (TKIs).

ELVN-001 is a small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with CML.

“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, Chief Medical Officer of Enliven. 

Related Content: Enliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says.

As of the cutoff date, March 18, 2024, 27 patients had enrolled in the ongoing Phase 1 clinical trial across five dose levels of ELVN-001, ranging from 10mg once daily (QD) to 120mg QD. 

ELVN-001 achieved a cumulative major molecular response (MMR) rate of 44% (7/16) by 12 weeks and demonstrated responses in patients with prior exposure to asciminib and who were TKI-resistant:

Among response-evaluable patients, all had improved or stable BCR::ABL1 transcript levels by 12 weeks.

ELVN-001 has been well tolerated, consistent with its selective kinase profile, with no ≥ Grade 3 treatment-related non-hematologic toxicities reported.

A maximum tolerated dose has not been identified, and there have been no dose reductions.

ELVN-001’s PK profile supports once-daily dosing with flexible administration requirements (no significant food effect and minimal risk of drug-drug interactions).

Price Action: ELVN shares are up 23.60% at $24.50 on the last check Thursday.

Continue Reading...

Popular

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

IBM Stock Jumps 5% After Quantum Computing Breakthrough

Shares of International Business Machines Corporation (NASDAQ: IBM) are up Thursday after the company announced it reached a technological milestone in quantum computin

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

BlackRock Turns Popular Mutual Funds Into Global Equity ETFs

BlackRock turns two top mutual funds into active ETFs, giving investors global equity exposure and strategies to manage volatility.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

AP Exclusive: Russia, Vietnam using energy profits to avoid possible US sanctions for arms deals

BANGKOK (AP) — Russia and Vietnam have developed a back-door method of concealing arms deal payments to avoid American and other Western sanctions, using the profits from joint oil and gas ventures to pay off defense contracts without any open transfers of cash through the global banking system, according to internal Vietnamese documents obtained by The Associated Press.

Canada's Carney heads to Mexico to discuss trade before a review of their US trade deal

TORONTO (AP) — Canadian Prime Minister Mark Carney heads to Mexico on Thursday in an effort to diversify trade as America’s neighbors brace for a review of the free trade deal with United States.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson

Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Amazon spends $1 billion to increase pay and lower health care costs for US workers

NEW YORK (AP) — Amazon says it's making a $1 billion investment to raise wages and lower the cost of health care plans for its U.S. fulfillment and transportation workers.

From Wall Street To Web3: Carbon Markets Move On-chain

Tokenization could boost transparency, reduce fraud, and increase liquidity in carbon markets.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Trump's Immigration Policies Could 'Shrink' GDP Growth As US Population Projected To Decline, Warns CBO

The U.S. population growth is expected to decline at a faster rate than previously projected due to President Donald Trump's immigration policies, according to the Congressional Budget Office (CBO).

Power, politics and performance: Russia's revamped Intervision song contest names a winner

When Vietnamese singer Duc Phuc held aloft the crystal cup trophy in Moscow’s Live Arena on Saturday night, he became the inaugural winner of — a Russian answer to Eurovision that some say is as much about politics and power as it is about performance.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Judge Tosses Trump's $15 Billion Case Against New York Times, President Claims He's 'Winning'

A federal judge dismissed Trump's $15 billion defamation lawsuit against The New York Times, calling it "decidedly improper," but gave him 28 days to resubmit it with a 40-page limit.

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

This Republican Lawmaker Wants Trump To Restrict Chinese Flights Amid Beijing's Rare Earth Embargo

Moolenaar calls for restrictions on Chinese flights to US in response to rare earth embargo amid 90% control of global rare earth supplies.

US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico

U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

In coastal Ghana, female oyster farmers try to save an old practice threatened by climate change

TSOKOMEY, Ghana (AP) — Beatrice Nutekpor weaves through the mangroves in Tsokomey community, just outside of Ghana’s capital of Accra, . It’s a family tradition she’s been doing since she was 15. Now 45, she is struggling to sustain the practice and pass it to her daughter.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Big Tech's energy-hungry data centers could be bumped off grids during power emergencies

HARRISBURG, Pa. (AP) — With the explosive growth of Big Tech's data centers threatening to overload U.S. electricity grids, policymakers are taking a hard look at a tough-love solution: bumping the energy-hungry data centers off grids during power emergencies.

UREVO Pushes Into US Wellness Market With New Ecosystem, Expects 50% Sales Surge in 2025

UREVO, the home fitness and wellness company, is making a strong bet on the U.S. market with its new wellness ecosystem, forecasting about 50% sales growth in 2025.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Block CEO Jack Dorsey Invites Businesses Using Square PoS System To Test Bitcoin Payments Feature

Jack Dorsey, co-founder and CEO of Block Inc. (NYSE:XYZ), on Monday encouraged merchants using the company's Square platform to test Bitcoin (CRYPTO: BTC) payments.

Scott Bessent Meets BlackRock's Rick Rieder As Trump Eyes Fed Chair Replacement For Jerome Powell: Report

Scott Bessent is interviewing candidates to replace Jerome Powell as Federal Reserve Chair by May 2026, with BlackRock's Rick Rieder among those being considered.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Lam Research And JSR Resolve Legal Disputes As They Team Up On AI Era Chips

Lam Research and JSR Corp agreed to collaborate and cross-license, combining their expertise to accelerate semiconductor manufacturing and reduce costs.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service